SCIENTIFIC BACKGROUND

ABCB7, ADGRG1, AFG3L2, ATP1A3, CACNA1A, CACNA1G, CACNB4, CCDC88C, DAB1, DNAJC5, DNMT1, EEF2, ELOVL4, ELOVL5, FGF14, GBA2, GJB1, ITPR1, KCNA1, KCNC3, KCND3, MME, PDYN, POLG, PRKCG, PRNP, PUM1, SCN2A, SLC1A3, SPTBN2, SYT14, TGM6, TMEM240, TRPC3, TTBK2, VAMP1

Scientific Background

Autosomal dominantly inherited cerebellar/spinocerebellar ataxias (ADCA/SCA) are a clinically and genetically heterogeneous group of diseases that includes more than 40 subtypes. The prevalence is estimated to be 0.001-0.005%. The genetic cause has not yet been clarified for all types. The leading clinical symptom of progressive ataxia is common in all forms. In addition to an unsteady gait, oculomotor and speech function disorders, trunk and extremity ataxia, intention tremor and additional neurological symptoms may occur. The age of manifestation is usually between 30 and 50 years of age. However, the disease can also begin in childhood or after the 6th decade.

 

The most common forms involve polyglutamine (polyQ) expansion disorders: ATXN1/SCA1, ATXN2/SCA2, ATXN3/SCA3, CACNA1A/SCA6, ATXN7/SCA7, TBP/SCA17 and ATN1/DRPLA. They are caused by pathological CAG triplet repeat expansions within different genes. As with other triplet repeat diseases, anticipation, i.e., an earlier age of onset of the disease and a more severe course in successive generations, is also observed in SCAs within families.

 

Three types are distinguishable depending on the clinical manifestation:

 

ADCA type 1: Cerebellar ataxia combined with ophthalmoplegia, dementia, extrapyramidal signs, optic atrophy and amyotrophy. One form of ADCA type 1 is SCA17, which is phenotypically variable and complex. Due to its broad clinical spectrum, SCA17 can mimic other neurodegenerative diseases, such as Huntington disease, Parkinson disease and other movement disorders and cerebellar diseases, and it has also been described in patients with only psychiatric symptoms (dementia, bipolar psychosis, paranoia, etc.) without ataxia or movement disorders. Due to the clinial similarity to Huntington disease, SCA17 is also called Huntington disease-like syndrome 4 (HDL4 ). If the clinical symptoms are unclear, molecular genetic diagnostics can be used to attempt a classification.

 

ADCA type 2: This type includes only SCA7, which is characterized by progressive cerebellar ataxia and retinal degeneration.

 

ADCA type 3: A group of pure cerebellar ataxias, the most common form of which is SCA6.

 

  • Spinocerebellar ataxia type 1 (ATXN1)
  • Spinocerebellar ataxia type 2 (ATXN2)
  • Spinocerebellar ataxia type 3 (ATXN3)
  • Spinocerebellar ataxia type 6 (CACNA1A)
  • Spinocerebellar ataxia type 7 (ATXN7)
  • Spinocerebellar ataxia type 17 (TBP)

 

References

Coarelli et al. 2018, F1000Research 7(F1000 Faculty Rev):1781 / Ashizawa et Xia 2016, Continuum (Minneap Minn) 22:1208 / Sun et al. 2016, Clin Genet 90:305 / Reetz et al. 2011, PLoS ONE 6:e15125 / Manto et Marmolino 2009, Curr Opin Neurol 22:419 / Gao et al. 2008, Eur J Hum Genet 16:215 / Ranum et Cooper 2006, Annu Rev Neurosci 29:259 / Riess et al. 2001, Dt Ärzteblatt 23:1319 / David et al. 1997, Nature Genet 17:65 / Zhuchenko et al. 1997, Nature Genet 15:62 / Imbert et al. 1996, Nature Genet 14:285 / Kawaguchi et al. 1994, Nature Genet 8:221

GENES

ABCB7, ADGRG1, AFG3L2, ATP1A3, CACNA1A, CACNA1G, CACNB4, CCDC88C, DAB1, DNAJC5, DNMT1, EEF2, ELOVL4, ELOVL5, FGF14, GBA2, GJB1, ITPR1, KCNA1, KCNC3, KCND3, MME, PDYN, POLG, PRKCG, PRNP, PUM1, SCN2A, SLC1A3, SPTBN2, SYT14, TGM6, TMEM240, TRPC3, TTBK2, VAMP1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more